Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer
- 1 September 2000
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 29 (3) , 197-203
- https://doi.org/10.1016/s0169-5002(00)00113-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Chromogranin A as Serum Marker for Neuroendocrine Neoplasia: Comparison with Neuron-Specific Enolase and the -Subunit of Glycoprotein HormonesJournal of Clinical Endocrinology & Metabolism, 1997
- Elevated Progastrin-Releasing Peptide(31-98) Concentrations in Pleural Effusions due to Small-Cell Lung CarcinomaRespiration, 1996
- Enzyme‐linked Immunosorbent Assay of Pro‐gastrin‐releasing Peptide for Small Cell Lung Cancer Patients in Comparison with Neuron‐specific Enolase MeasurementJapanese Journal of Cancer Research, 1995
- Serum neuron-specific enolase and immunohistochemical markers of neuroendocrine differentiation in lung cancerIrish Journal of Medical Science, 1995
- Inability of serum neuron-specific enolase to predict disease extent in small cell lung cancerEuropean Journal Of Cancer, 1993
- A computer program for non-parametric receiver operating characteristic analysisComputer Methods and Programs in Biomedicine, 1993
- Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Neuron-specific enolase (NSE): A useful marker in small cell lung cancerLung Cancer, 1987
- Serum Neuron-Specific EnolaseChest, 1985
- SERUM NEURON-SPECIFIC ENOLASE: A MARKER FOR DISEASE EXTENT AND RESPONSE TO THERAPY OF SMALL-CELL LUNG CANCERThe Lancet, 1982